Second Sight Medical Products, Inc. (EYES): Price and Financial Metrics


Second Sight Medical Products, Inc. (EYES): $3.51

0.13 (+3.85%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

EYES Stock Summary

  • For EYES, its debt to operating expenses ratio is greater than that reported by only 0.46% of US equities we're observing.
  • With a year-over-year growth in debt of -100%, Second Sight Medical Products Inc's debt growth rate surpasses merely 0% of about US stocks.
  • The volatility of Second Sight Medical Products Inc's share price is greater than that of 99.68% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Second Sight Medical Products Inc are SEAC, AEIS, ASTC, GEOS, and ITRI.
  • EYES's SEC filings can be seen here. And to visit Second Sight Medical Products Inc's official web site, go to www.secondsight.com.

EYES Stock Price Chart Interactive Chart >

Price chart for EYES

EYES Price/Volume Stats

Current price $3.51 52-week high $20.00
Prev. close $3.38 52-week low $0.72
Day low $3.34 Volume 606,881
Day high $3.52 Avg. volume 10,961,363
50-day MA $3.72 Dividend yield N/A
200-day MA $4.83 Market Cap 138.33M

Second Sight Medical Products, Inc. (EYES) Company Bio


Second Sight Medical Products develops, manufactures, and markets implantable prosthetic devices to restore functional vision to blind patients in the United States, Canada, Europe, and Saudi Arabia. The company was founded in 1998 and is based in Sylmar, California.


EYES Latest News Stream


Event/Time News Detail
Loading, please wait...

EYES Latest Social Stream


Loading social stream, please wait...

View Full EYES Social Stream

Latest EYES News From Around the Web

Below are the latest news stories about Second Sight Medical Products Inc that investors may wish to consider to help them evaluate EYES as an investment opportunity.

Second Sight Medical Products Announces a New NIH Grant Supplement for Its Orion Study

LOS ANGELES, August 11, 2021--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or "Second Sight"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announces that the Company received a grant supplement from the National Institutes of Health (NIH) to fund a qualitative study to gather critical insights into how profoundly blind people weigh the risks and benefits of visual neuroprostheses

Yahoo | August 11, 2021

EYES Stock: The Artificial Vision News That Has Investors Looking at Second Sight

EYES stock is set for another day of double-digit gains after the European patent agency approved the company's application.

Robert Lakin on InvestorPlace | July 22, 2021

CLOV Stock: What Reddit Investors Are Saying About Clover Health Today as Shares Climb

Clover Health (CLOV) stock is falling on Thursday after meme stock was pushed higher earlier this week thanks to a Reddit rally.

William White on InvestorPlace | July 22, 2021

MRIN Stock: 10 Things for Marin Software Investors to Know About the Popular Meme Stock Today

Marin Software (MRIN) stock is taking a beating on Thursday following rallying prices over the last couple of days thanks to retail traders.

William White on InvestorPlace | July 22, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning!

William White on InvestorPlace | July 22, 2021

Read More 'EYES' Stories Here

EYES Price Returns

1-mo -5.65%
3-mo -31.98%
6-mo -61.47%
1-year 320.51%
3-year -76.28%
5-year -86.66%
YTD 87.70%
2020 -68.50%
2019 -16.63%
2018 -53.40%
2017 -3.05%
2016 -66.55%

Continue Researching EYES

Want to see what other sources are saying about Second Sight Medical Products Inc's financials and stock price? Try the links below:

Second Sight Medical Products Inc (EYES) Stock Price | Nasdaq
Second Sight Medical Products Inc (EYES) Stock Quote, History and News - Yahoo Finance
Second Sight Medical Products Inc (EYES) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 2.7147 seconds.